- Home
- DMRC vs NPCE Comparison
DMRC vs NPCE Comparison
Compare DMRC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- NPCE
- Stock Information
- Founded
- DMRC 2008
- NPCE 1997
- Country
- DMRC United States
- NPCE United States
- Employees
- DMRC N/A
- NPCE N/A
- Industry
- DMRC EDP Services
- NPCE Medical Specialities
- Sector
- DMRC Technology
- NPCE Health Care
- Exchange
- DMRC Nasdaq
- NPCE Nasdaq
- Market Cap
- DMRC 275.4M
- NPCE 312.2M
- IPO Year
- DMRC N/A
- NPCE 2021
- Fundamental
- Price
- DMRC $12.17
- NPCE $8.98
- Analyst Decision
- DMRC Strong Buy
- NPCE Strong Buy
- Analyst Count
- DMRC 1
- NPCE 6
- Target Price
- DMRC $30.00
- NPCE $16.33
- AVG Volume (30 Days)
- DMRC 135.5K
- NPCE 340.9K
- Earning Date
- DMRC 08-14-2025
- NPCE 08-12-2025
- Dividend Yield
- DMRC N/A
- NPCE N/A
- EPS Growth
- DMRC N/A
- NPCE N/A
- EPS
- DMRC N/A
- NPCE N/A
- Revenue
- DMRC $37,848,000.00
- NPCE $84,306,000.00
- Revenue This Year
- DMRC N/A
- NPCE $21.04
- Revenue Next Year
- DMRC $4.21
- NPCE $10.73
- P/E Ratio
- DMRC N/A
- NPCE N/A
- Revenue Growth
- DMRC 2.44
- NPCE 22.05
- 52 Week Low
- DMRC $10.44
- NPCE $5.45
- 52 Week High
- DMRC $48.32
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- DMRC 38.24
- NPCE 31.44
- Support Level
- DMRC $12.21
- NPCE $9.00
- Resistance Level
- DMRC $12.88
- NPCE $9.61
- Average True Range (ATR)
- DMRC 0.46
- NPCE 0.42
- MACD
- DMRC -0.08
- NPCE 0.05
- Stochastic Oscillator
- DMRC 3.64
- NPCE 10.61
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.